BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22817761)

  • 1. Balanced ultrafiltration: inflammatory mediator removal capacity.
    Guan Y; Wan C; Wang S; Sun P; Long C
    Artif Organs; 2012 Oct; 36(10):894-900. PubMed ID: 22817761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamic observation of plasma concentration of antimicrobial agents during balanced ultrafiltration in vitro.
    Fang Y; Guan Y; Wan C; Fu Z; Jiang J; Wu C; Zhao J; Sun P; Long C
    Artif Organs; 2014 Jan; 38(1):48-55. PubMed ID: 23865445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations.
    Wang MJ; Chiu IS; Hsu CM; Wang CM; Lin PL; Chang CI; Huang CH; Chu SH
    Ann Thorac Surg; 1996 Feb; 61(2):651-6. PubMed ID: 8572782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants.
    Böning A; Scheewe J; Ivers T; Friedrich C; Stieh J; Freitag S; Cremer JT
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1458-65. PubMed ID: 15116008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type.
    Berdat PA; Eichenberger E; Ebell J; Pfammatter JP; Pavlovic M; Zobrist C; Gygax E; Nydegger U; Carrel T
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1688-96. PubMed ID: 15173725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery.
    McBride WT; Armstrong MA; Gilliland H; McMurray TJ
    Cytokine; 1996 Sep; 8(9):724-9. PubMed ID: 8932984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of sieving coefficients to determine the efficacy of the hemoconcentrator in removal of four inflammatory mediators produced during cardiopulmonary bypass.
    Clar A; Bowers MC; Larson DF
    ASAIO J; 1997; 43(3):163-70. PubMed ID: 9152485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass.
    Tallman RD; Dumond M; Brown D
    Perfusion; 2002 Mar; 17(2):111-5. PubMed ID: 11958301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
    Mariano F; Fonsato V; Lanfranco G; Pohlmeier R; Ronco C; Triolo G; Camussi G; Tetta C; Passlick-Deetjen J
    Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model.
    Li M; Xue J; Liu J; Kuang D; Gu Y; Lin S
    Ther Apher Dial; 2011 Feb; 15(1):98-108. PubMed ID: 21272259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass.
    Liu J; Ji B; Long C; Li C; Feng Z
    Artif Organs; 2007 Jul; 31(7):571-5. PubMed ID: 17584482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines.
    Nagaki M; Hughes RD; Keane HM; Lau JY; Williams R
    Circ Shock; 1992 Nov; 38(3):182-8. PubMed ID: 1292881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrafiltration after cardiopulmonary bypass in children: effects on hemodynamics, cytokines and complement.
    Saatvedt K; Lindberg H; Geiran OR; Michelsen S; Pedersen T; Seem E; Mollnes TE
    Cardiovasc Res; 1996 Apr; 31(4):596-602. PubMed ID: 8689651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modified ultrafiltration on inflammatory mediators, coagulation factors, and other proteins in blood after an extracorporeal circuit.
    Fujita M; Ishihara M; Kusama Y; Shimizu M; Kimura T; Iizuka Y; Ozaki S; Muraoka M; Morimoto Y; Takeshima S; Kikuchi M; Maehara T
    Artif Organs; 2004 Mar; 28(3):310-3. PubMed ID: 15046631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of cytokines and hemodynamic instability during the reperfusion of a liver graft.
    Bezinover D; Kadry Z; McCullough P; McQuillan PM; Uemura T; Welker K; Mastro AM; Janicki PK
    Liver Transpl; 2011 Mar; 17(3):324-30. PubMed ID: 21384515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation?
    Denizot Y; Feiss P; Nathan N
    Cytokine; 1999 Apr; 11(4):301-4. PubMed ID: 10328869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flow rate, negative pressure, and duration of modified ultrafiltration on hemodynamics and inflammatory mediators.
    Wang W; Zhu DM; Huang HM; Cai XM; Xu C; Jlang LM; Shen LS
    ASAIO J; 2007; 53(1):41-5. PubMed ID: 17237648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Quadrox-I neonatal oxygenator with an integrated arterial filter.
    Salavitabar A; Qiu F; Kunselman A; Ündar A
    Perfusion; 2010 Nov; 25(6):409-15. PubMed ID: 20699287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery.
    Blomquist S; Gustafsson V; Manolopoulos T; Pierre L
    Perfusion; 2009 Jan; 24(1):13-7. PubMed ID: 19567543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of interleukin-10 on expression of inflammatory mediators and anti-inflammatory mediators during acute lung injury in rats].
    Li HX; Zhang JC; Zhao YL; Hao HJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jun; 17(6):338-41. PubMed ID: 15970097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.